Significant antitumor effect of an antibody against TMEM180, a new colorectal cancer-specific molecule

Masahiro Yasunaga1, Shinji Saijou1, Shingo Hanaoka1

  • 1Division of Developmental Therapeutics, Exploratory Oncology Research & Clinical Trial Centre, National Cancer Centre, Kashiwa, Japan.

Cancer Science
|December 12, 2018
PubMed

Insights

Researchers discovered TMEM180, a novel colorectal cancer (CRC) target. An antibody targeting TMEM180 shows promise for CRC diagnosis and antibody-based therapy, eradicating tumors in preclinical models.

Area of Science:

  • Oncology
  • Molecular Biology
  • Immunology

Background:

  • Current colorectal cancer (CRC) therapies are insufficient, necessitating novel therapeutic targets.
  • TMEM180, an 11-pass transmembrane protein functioning as a cation symporter, has been identified as a CRC-specific molecule.

Purpose of the Study:

  • To investigate TMEM180 as a potential diagnostic marker and therapeutic target for colorectal cancer.
  • To develop and characterize an anti-TMEM180 monoclonal antibody (mAb) for CRC treatment.

Main Methods:

  • Development and humanization of an anti-TMEM180 mAb.
  • Immunohistochemistry (IHC) to assess TMEM180 expression in CRC tissues and normal organs.
  • Immune electron microscopy to localize TMEM180 on tumor exosomes.
  • Assessment of TMEM180 upregulation under hypoxic conditions.
  • Evaluation of in vitro antibody-dependent cell-mediated cytotoxicity (ADCC) and complement-dependent cytotoxicity (CDC).
  • In vivo efficacy study using SW480 CRC xenografts.

Main Results:

  • TMEM180 is specifically expressed in CRC with minimal staining in major organs.
  • TMEM180 is localized on tumor exosomes and its expression is upregulated under hypoxia.
  • The anti-TMEM180 mAb demonstrated significant in vitro cytotoxic activity (ADCC and CDC).
  • SW480 CRC xenografts were eradicated by the anti-TMEM180 mAb treatment.

Conclusions:

  • TMEM180 represents a promising new biomarker for colorectal cancer.
  • An antibody targeting TMEM180 holds potential for novel antibody-based CRC therapy.

Related Concept Videos

Molecules and Compounds02:38

Molecules and Compounds

Atoms and Molecules
68.7K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.5K
Specific Heat01:16

Specific Heat

The specific heat capacity of a substance refers to the energy required to increase the temperature of one gram of that substance by one degree Celcius. Specific heat capacity is often represented in calories (cal), grams (g), and degrees Celsius (oC), but can also be expressed in joules (J), kilograms (kg), and Kelvin (K), among other units.
For example, increasing the temperature of one gram of water by 1°C requires one calorie of heat energy and can be written as 1 cal/g-°C, or...
67.4K
Positive Regulator Molecules01:45

Positive Regulator Molecules

To consistently produce healthy cells, the cell cycle—the process that generates daughter cells—must be precisely regulated.
136.2K
Antibody Actions01:26

Antibody Actions

Antibodies, or immunoglobulins, are critical players in the immune system's arsenal against invading pathogens. Produced by B cells and plasma cells, their primary role is to detect and bind to specific antigens, molecules found on the surface of pathogens like bacteria or viruses. Beyond antigen recognition, antibodies perform several vital functions that contribute to immune defense.
Neutralization
Antibodies can bind to pathogens, preventing them from infecting host cells. This process...
2.7K
Conservative Site-specific Recombination and Phase Variation02:53

Conservative Site-specific Recombination and Phase Variation

Because the DNA segments are cut and reorganized in a direction-specific manner, site-specific recombination has emerged as an efficient genetic engineering technique. Flippase and Cyclization recombinases or Flp and Cre, respectively, are two members of the tyrosine recombinase family derived from bacteriophages, that are used to mediate site-specific DNA insertions, deletions, and targeted expression of proteins in mammalian cell lines.
The recognition sites for Cre recombinase called LoxP...
6.8K